share_log

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga ·  Feb 13 01:31

Gainers

  • Renalytix (NASDAQ:RNLX) stock rose 490.4% to $2.25 during Monday's regular session. The market value of their outstanding shares is at $112.4 million.
  • Regencell Bioscience (NASDAQ:RGC) stock rose 39.91% to $10.39. The market value of their outstanding shares is at $135.2 million.
  • Genenta Science (NASDAQ:GNTA) shares increased by 31.84% to $4.14. The market value of their outstanding shares is at $75.4 million.
  • T2 Biosystems (NASDAQ:TTOO) stock rose 29.94% to $6.35. The company's market cap stands at $25.7 million.
  • Sangamo Therapeutics (NASDAQ:SGMO) stock moved upwards by 26.04% to $0.72. The company's market cap stands at $128.3 million.
  • Organovo Holdings (NASDAQ:ONVO) shares moved upwards by 25.55% to $1.13. The market value of their outstanding shares is at $11.3 million. As per the press release, Q3 earnings came out 2 days ago.

Losers

  • AN2 Therapeutics (NASDAQ:ANTX) stock decreased by 75.0% to $5.01 during Monday's regular session. The company's market cap stands at $149.0 million.
  • InVivo Therapeutics Hldg (NASDAQ:NVIV) shares declined by 33.39% to $0.33. The company's market cap stands at $1.0 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares fell 28.95% to $1.08.
  • NanoString Technologies (NASDAQ:NSTG) shares declined by 22.18% to $0.18. The market value of their outstanding shares is at $8.6 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 18.58% to $5.51. The company's market cap stands at $4.0 million. The company's, Q2 earnings came out yesterday.
  • OneMedNet (NASDAQ:ONMD) shares decreased by 18.18% to $0.9. The market value of their outstanding shares is at $29.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment